MALIGNANT NEOPLASMS
Clinical trials for MALIGNANT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to shrink kidney tumors in Second-Line treatment
Disease control Recruiting nowThis study tests whether adding the experimental drug SLC-3010 to the standard drug axitinib works better than axitinib alone for people with advanced clear cell kidney cancer that has worsened after first treatment. About 78 adults will be randomly assigned to one of the two gro…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 03:59 UTC
-
New pill takes on Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study tests a new daily pill, DEG6498, in about 100 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and understand side effects. Participants take the drug once a day and are closely watched by…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Degron Therapeutics Co. • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New pill combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new experimental drug (PF-07799544) combined with another drug (PF-07799933) in adults with advanced solid tumors that have a specific gene change called BRAF V600. The goal is to see if the combination is safe and can shrink or control the cancer. Participants…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Scientists seek tissue samples to unlock cancer secrets
Knowledge-focused Recruiting nowThis study collects blood, urine, saliva, and tissue samples from people who have or may have cancer, as well as their blood relatives. The goal is to help researchers learn more about the genetic and molecular causes of cancer. No direct treatment is given, but the samples may l…
Matched conditions: MALIGNANT NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC